regulation
EU Advisor Recommends Regulatory Exemption for Gene Editing
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 
USDA Buys Animals from Farm It Reported for Animal Welfare Abuses
USDA Buys Animals from Farm It Reported for Animal Welfare Abuses
Katarina Zimmer | Nov 14, 2017
The federal agency has so far not taken any enforcement action against Ruby Fur Farm. 
Mass Resignation from <em>Scientific Reports</em>’s Editorial Board
Mass Resignation from Scientific Reports’s Editorial Board
Catherine Offord | Nov 6, 2017
Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.
Report: Security Lapses in Handling of Deadly Pathogens
Report: Security Lapses in Handling of Deadly Pathogens
Katarina Zimmer | Oct 31, 2017
A government report finds that laboratories in the U.S. that work with select agents such as Ebola and anthrax aren’t as secure as they should be.
WHO Cherry-Picked Data on Pesticide, Investigation Finds
WHO Cherry-Picked Data on Pesticide, Investigation Finds
Ashley P. Taylor | Oct 22, 2017
A group evaluating glyphosate’s cancer risk omitted evidence that the chemical is not carcinogenic.
Great Lakes Gray Wolf to Retain Endangered Status
Great Lakes Gray Wolf to Retain Endangered Status
Catherine Offord | Aug 2, 2017
A US Court of Appeals ruled that the Interior Department acted prematurely in removing the animals from the endangered species list.
New FDA Pathway to Accelerate Development of Cell Therapies
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Contributors
Contributors
Diana Kwon | Apr 1, 2017
Meet some of the people featured in the April 2017 issue of The Scientist.
Book Excerpt from <em>The Politics of Cancer</em>
Book Excerpt from The Politics of Cancer
Wendy N. Whitman Cobb | Mar 31, 2017
In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.